Parmis, Alventor S.

HRN: 03-01-03  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/21/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
11/21/2023
11/27/2023
IV
1.5 Grams
Q 6 Hrs
Cellulitis
Checking Final Appropriateness 
11/21/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
11/21/2023
11/27/2023
IV
600 Mg
Q 8 Hours
Cel
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: